1. Buyon, JP, Hiebert, R, Copel, J, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998; 31(7): 1658–1666.
Google Scholar | Crossref | Medline2. Jaeggi, E, Laskin, C, Hamilton, R, et al. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus. J Am Coll Cardiol 2010; 55(24): 2778–2784.
Google Scholar | Crossref | Medline3. Vanoni, F, Lava, SAG, Fossali, EF, et al. Neonatal systemic lupus erythematosus syndrome: a comprehensive review. Clin Rev Allergy Immunol 2017; 53(3): 469–476.
Google Scholar | Crossref | Medline4. Wisuthsarewong, W, Soongswang, J, Chantorn, R. Neonatal lupus erythematosus: clinical character, investigation, and outcome. Pediatr Dermatol 2011; 28(2): 115–121.
Google Scholar | Crossref | Medline5. Lee, LA . The clinical spectrum of neonatal lupus. Arch Dermatol Res 2009; 301(1): 107–110.
Google Scholar | Crossref | Medline6. Lun Hon, K, Leung, AKC. Neonatal lupus erythematosus. Autoimmune Dis 2012; 2012: 1–6.
Google Scholar | Crossref7. Tsuboi, H, Sumida, T, Noma, H, et al. Maternal predictive factors for fetal congenital heart block in pregnant mothers positive for anti-SS-A antibodies. Mod Rheumatol 2016; 26(4): 569–575.
Google Scholar | Crossref | Medline8. Cuneo, BF, Buyon, JP. Keeping upbeat to prevent the heartbreak of anti‐Ro/SSA pregnancy. Ultrasound Obstet Gynecol 2019; 54(1): 7–9.
Google Scholar | Crossref | Medline9. Izmirly, PM, Saxena, A, Kim, MY, et al. Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. Circulation 2011; 124(18): 1927–1935.
Google Scholar | Crossref | Medline10. Limaye, MA, Buyon, JP, Cuneo, BF, et al. A review of fetal and neonatal consequences of maternal systemic lupus erythematosus. Prenatal Diagn 2020; 40: 1066–1076.
Google Scholar | Crossref | Medline11. Llanos, C, Izmirly, PM, Katholi, M, et al. Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors. Arthritis Rheum 2009; 60(10): 3091–3097.
Google Scholar | Crossref | Medline12. Izmirly, PM, Kim, MY, Llanos, C, et al. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann Rheum Dis 2010; 69(10): 1827–1830.
Google Scholar | Crossref | Medline13. Ambrosi, A, Salomonsson, S, Eliasson, H, et al. Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern. Ann Rheum Dis 2012; 71(3): 334–340.
Google Scholar | Crossref | Medline14. Tunks, RD, Clowse, ME, Miller, SG, et al. Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents. Am J Obstet Gynecol 2013; 208(1): 64–67.
Google Scholar | Crossref | Medline15. Anami, A, Fukushima, K, Takasaki, Y, et al. The predictive value of anti-SS-A antibodies titration in pregnant women with fetal congenital heart block. Mod Rheumatol 2013; 23(4): 653–658.
Google Scholar | Crossref | Medline16. Barsalou, J, Costedoat-Chalumeau, N, Berhanu, A, et al. Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus. Ann Rheum Dis 2018; 77(12): 1742–1749.
Google Scholar | Crossref | Medline17. Li, YQ, Wang, Q, Luo, Y, et al. Neonatal lupus erythematosus: a review of 123 cases in China. Int J Rheum Dis 2015; 18(7): 761–767.
Google Scholar | Crossref | Medline18. Buyon, JP, Winchester, RJ, Slade, SG, et al. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies. Arthritis Rheum 1993; 36(9): 1263–1273.
Google Scholar | Crossref | Medline19. Martínez-Sánchez, N, Pérez-Pinto, S, Robles-Marhuenda, Á, et al. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study. Immunol Res 2017; 65(2): 487–494.
Google Scholar | Crossref | Medline20. Silverman, E, Mamula, M, Hardin, JA, et al. Importance of the immune response to the Ro/La particle in the development of congenital heart block and neonatal lupus erythematosus. J Rheumatol 1991; 18(1): 120–124.
Google Scholar | Medline21. Izmirly, PM, Llanos, C, Lee, LA, et al. Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block. Arthritis Rheum 2010; 62(4): 1153–1157.
Google Scholar | Crossref | Medline22. Kan, N, Silverman, ED, Kingdom, J, et al. Serial echocardiography for immune-mediated heart disease in the fetus: results of a risk-based prospective surveillance strategy. Prenat Diagn 2017; 37(4): 375–382.
Google Scholar | Crossref | Medline23. Sonesson, SE, Ambrosi, A, Wahren‐Herlenius, M. Benefits of fetal echocardiographic surveillance in pregnancies at risk of congenital heart block: single‐center study of 212 anti‐Ro52‐positive pregnancies. Ultrasound Obstet Gynecol 2019; 54(1): 87–95.
Google Scholar | Crossref | Medline24. Friedman, DM, Kim, MY, Copel, JA, et al. Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study. Am J Cardiol 2009; 103(8): 1102–1106.
Google Scholar | Crossref | Medline25. Izmirly, P, Saxena, A, Buyon, JP. Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus. Curr Opin Rheumatol 2017; 29(5): 467–472.
Google Scholar | Crossref | Medline26. Li, JM, Horsfall, AC, Maini, RN. Anti-La (SS-B) but not anti-Ro52 (SS-A) antibodies cross-react with laminin--a role in the pathogenesis of congenital heart block? Clin Exp Immunol 1995; 99(3): 316–324.
Google Scholar | Crossref | Medline27. Dorner, T, Feist, E, Chaoui, R, et al. Enhanced frequency of autoimmune congenital heart block in female offspring. Rheumatology 1999; 38(4): 380–382.
Google Scholar | Crossref | Medline28. Morel, N, Lévesque, K, Maltret, A, et al. Incidence, risk factors, and mortality of neonatal and late-onset dilated cardiomyopathy associated with cardiac neonatal lupus. Int J Cardiol 2017; 248: 263–269.
Google Scholar | Crossref | Medline29. Buyon, JP, Clancy, RM. Neonatal Lupus: Review of Proposed Pathogenesis and Clinical Data from the US-based Research Registry for Neonatal Lupus. Autoimmunity 2003; 36(1): 41–50.
Google Scholar | Crossref | Medline30. Kobayashi, R, Mii, S, Nakano, T, et al. Neonatal lupus erythematosus in Japan: a review of the literature. Autoimmun Rev 2009; 8(6): 462–466.
Google Scholar | Crossref | Medline31. Fredi, M, Andreoli, L, Bacco, B, et al. First report of the Italian registry on immune-mediated congenital heart block (Lu.Ne registry). Front Cardiovasc Med 2019; 6: 11.
Google Scholar | Crossref | Medline32. Lee, SY, Sim, JH, Park, YL, et al. Neonatal lupus erythematosus in South Korea: clinical and serologic features. J Clin Exp Dermatol Res 2011; 2(3).
Google Scholar | Medline33. Gryka-Marton, M, Szukiewicz, D, Teliga-Czajkowska, J, et al. An overview of neonatal lupus with anti-Ro characteristics. Int J Mol Sci 2021; 22(17).
Google Scholar | Crossref | Medline34. Weckerle, CE, Niewold, TB. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clin Rev Allergy Immunol 2011; 40(1): 42–49.
Google Scholar | Crossref | Medline | ISI35. Izmirly, PM, Costedoat-Chalumeau, N, Pisoni, CN, et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation 2012; 126(1): 76–82.
Google Scholar | Crossref | Medline | ISI36. Barsalou, J, Jaeggi, E, Laskin, CA, et al. Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study. Rheumatology 2017; 56(9): 1552–1559.
Google Scholar | Crossref | Medline37. Izmirly, P, Kim, M, Friedman, DM, et al. Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA/Ro-positive mothers. J Am Coll Cardiol 2020; 76(3): 292–302.
Google Scholar | Crossref | Medline38. Silverman, ED, Buyon, J, Laxer, RM, et al. Autoantibody response to the Ro/La particle may predict outcome in neonatal lupus erythematosus. Clin Exp Immunol 1995; 100(3): 499–505.
Google Scholar | Crossref | Medline39. Yukiko, N . Immune responses to SS-A 52-kDa and 60-kDa proteins and to SS-B 50-kDa protein in mothers of infants with neonatal lupus erythematosus. Br J Dermatol 2000; 142(5): 908–912.
Google Scholar | Crossref | Medline40. Eronen, M, Miettinen, A, Walle, T, et al. Relationship of maternal autoimmune response to clinical manifestations in children with congenital complete heart block. Acta Paediatr 2004; 93(6): 803–809.
Google Scholar | Crossref | Medline41. Tran, HB, Macardle, PJ, Hiscock, J, et al. Anti-La/SSB antibodies transported across the placenta bind apoptotic cells in fetal organs targeted in neonatal lupus. Arthritis Rheum 2002; 46(6): 1572–1579.
Google Scholar | Crossref | Medline42. Lee, LA . Neonatal lupus erythematosus: clinical findings and pathogenesis. J Invest Dermatol Symp Proc 2004; 9(1): 52–56.
Google Scholar | Crossref | Medline43. Neiman, AR, Lee, LA, Weston, WL, et al. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J Pediatr 2000; 137(5): 674–680.
Google Scholar | Crossref | Medline44. Silverman, E, Jaeggi, E. Non-cardiac manifestations of neonatal lupus erythematosus. Scand J Immunol 2010; 72(3): 223–225.
Google Scholar | Crossref | Medline45. Jones, SK . The effects of hormonal and other stimuli on cell-surface Ro/SSA antigen expression by human keratinocytes in vitro: their possible role in the induction of cutaneous lupus lesions. Br J Dermatol 1992; 126(6): 554–560.
Google Scholar | Crossref | Medline46. Wallace, DJ, Gudsoorkar, VS, Weisman, MH, et al. New insights into mechanisms of therapeutic effects of antimalarial agents in SLE. Nat Rev Rheumatol 2012; 8(9): 522–533.
Google Scholar | Crossref | Medline47. Guiducci, C, Tripodo, C, Gong, M, et al. Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9. J Exp Med 2010; 207(13): 2931–2942.
Google Scholar | Crossref | Medline48. Francès, C, Cosnes, A, Duhaut, P, et al. Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study. Arch Dermatol 2012; 148(4): 479–484.
Google Scholar | Crossref | Medline